Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 2/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3887243 | 0.97 | KCNN4 (0.45) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| Bromide SCHEMBL10962749 | 0.94 | KCNN4 (0.43) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| SCHEMBL8982011 | 0.79 | KCNN4 (0.47) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| SCHEMBL19457729 | 0.73 | KCNN4 (0.43) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| SCHEMBL17844155 | 0.73 | MAPK1 (0.50) | KCNN4ALDH1A1TSHRMAPK1TAAR1 | |
| SCHEMBL3082162 | 0.73 | MAPK1 (0.50) | KCNN4ALDH1A1TSHRMAPK1TAAR1 | |
| SCHEMBL50795 | 0.71 | KCNN4 (0.41) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| SCHEMBL230628 | 0.69 | KCNN4 (0.53) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| SCHEMBL8178 | 0.69 | KCNN4 (0.53) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| SCHEMBL1820058 | 0.69 | KCNN4 (0.39) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 567 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12338326-B2 | Polyamides with pendent optical absorbers and related methods | XEROX CORPORATION (US) | 2025-06-24 | — | — | US | claimed |
| CN-119490543-A | Preparation method of bridged metallocene compound, bridged metallocene compound obtained by preparation method and application of bridged metallocene compound | 中国石油化工股份有限公司 | 2025-02-21 | — | — | CN | claimed |
| CN-118994506-A | Styrene-butadiene polymer and preparation method thereof, toughening agent composition and ABS resin | 中国石油化工股份有限公司 | 2024-11-22 | — | — | CN | claimed |
| CN-113461857-B | Low cis-polybutadiene rubber and preparation method thereof, HIPS and preparation method thereof | 中国石油化工股份有限公司 | 2024-11-19 | — | — | CN | claimed |
| CN-112457487-B | Polyamide with overhanging optical absorbers and related methods | 施乐公司 | 2024-10-01 | — | — | CN | claimed |
| US-12065395-B2 | Processes for the preparation of deuterated D-serine | SUN PHARMACEUTICAL INDUSTRIES, INC. (US) | 2024-08-20 | — | — | US | claimed |
| CN-113461858-B | Low cis-polybutadiene rubber and preparation method thereof, HIPS and preparation method thereof | 中国石油化工股份有限公司 | 2024-07-02 | — | — | CN | claimed |
| US-20230374218-A1 | POLYAMIDES WITH PENDENT OPTICAL ABSORBERS AND RELATED METHODS | XEROX CORPORATION (US) | 2023-11-23 | — | — | US | claimed |
| US-11753505-B2 | Polyamides with pendent optical absorbers and related methods | XEROX CORPORATION (US) | 2023-09-12 | — | — | US | claimed |
| CN-113461858-A | Low cis-polybutadiene rubber and preparation method thereof, and HIPS and preparation method thereof | 中国石油化工股份有限公司 | 2021-10-01 | — | — | CN | claimed |
| US-5518528-A | ABSORPTION AND DESORPTION OF BORON TRIFLUORIDE OR SIMILAR COMPOUNDS AND SEMICONDUCTORS | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 1996-05-21 | — | — | US | claimed |
| WO-1996011739-A1 | STORAGE AND DELIVERY SYSTEM FOR GASEOUS COMPOUNDS | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 1996-04-25 | — | — | WO | claimed |
| WO-1995024404-A1 | PREPARATION OF SYMMETRICAL AND UNSYMMETRICAL DITHIIN COMPOUNDS | SHAMAN PHARMACEUTICALS, INC. (US) | 1995-09-14 | — | — | WO | claimed |
| EP-0511001-A2 | Ring-closure method for 1-carbacephalosporin six-membered ring | ELI LILLY AND COMPANY (US) | 1992-10-28 | — | — | EP | claimed |
| US-5089610-A | Reacting with a strong base, anhydrous conditions, inert solvent, dehydrating | ELI LILLY AND COMPANY (US) | 1992-02-18 | — | — | US | claimed |
| US-4525309-A | Lewis acid catalysis of the homologation of boronic esters with haloalkylmetal reagents | WASHINGTON STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 1985-06-25 | — | — | US | claimed |
| US-4307232-A | Preparation of dialkyl- and diarylphosphonoalkanoic acids and substituted acrylic acids | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-12-22 | — | — | US | claimed |
| US-4012431-A | Process for preparing 5-oxa PGF1.sub.α -type compounds | THE UPJOHN COMPANY (US) | 1977-03-15 | — | — | US | claimed |
| US-3968109-A | ANTIBIOTIC | E. R. SQUIBB & SONS, INC. (US) | 1976-07-06 | — | — | US | claimed |
| US-3941779-A | Method for producing 2-(substituted thio)-3-cephem derivatives | E. R. SQUIBB & SONS, INC. (US) | 1976-03-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12065395-B2 | Processes for the preparation of deuterated D-serine | PSPH, SRR, DHPS | KCNN4 4813/4885ALDH1A1 3327/4885TSHR 3758/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.